Market Capitalization of GlaxoSmithKline Pharmaceuticals (GLAXO)
As of July 24, 2026, GlaxoSmithKline Pharmaceuticals (GLAXO) market capitalisation is ₹43391.66 Cr ($4.82B), with 17.26 Cr shares outstanding at a current price of ₹2514.30 on NSE, ranking 222 out of 5363 companies by market cap in our screener. GlaxoSmithKline Pharmaceuticals operates in the Healthcare sector and is classified as a Large Cap stock. For live price, earnings and the complete company profile, see GlaxoSmithKline Pharmaceutical stock price NSE.
Market Cap History of GlaxoSmithKline Pharmaceuticals (Last 10 Years)
GLAXO market capitalisation from year-end NSE closing prices over the last 10 years. View GLAXO 52-week performance for the annual high/low range and current price position.
End of Year Market Cap History — GlaxoSmithKline Pharmaceuticals
GLAXO year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. Compare with GLAXO stock valuation models to assess whether the stock is under or overvalued.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹43391.66 Cr
$4.82B USD
|
₹2514.30 | NSE | +1.65% |
| 2025 |
₹42689.26 Cr
$4.74B USD
|
₹2473.60 | NSE | +9.85% |
| 2024 |
₹38862.31 Cr
$4.32B USD
|
₹2251.85 | NSE | +18.63% |
| 2023 |
₹32758.18 Cr
$3.64B USD
|
₹1898.15 | NSE | +43.94% |
| 2022 |
₹22758.92 Cr
$2.53B USD
|
₹1318.75 | NSE | -24.93% |
| 2021 |
₹30316.18 Cr
$3.37B USD
|
₹1756.65 | NSE | +8.17% |
| 2020 |
₹28026.05 Cr
$3.11B USD
|
₹1623.95 | NSE | +0.85% |
| 2019 |
₹27790.47 Cr
$3.09B USD
|
₹1610.30 | NSE | +6.27% |
| 2018 |
₹26151.83 Cr
$2.91B USD
|
₹1515.35 | NSE | +21.75% |
| 2017 |
₹21480.11 Cr
$2.39B USD
|
₹1244.65 | NSE | -8.81% |
| 2016 |
₹23555.37 Cr
$2.62B USD
|
₹1364.90 | NSE | -17.63% |
| 2015 |
₹28596.94 Cr
$3.18B USD
|
₹1657.03 | NSE | +3.61% |
| 2014 |
₹27599.43 Cr
$3.07B USD
|
₹1599.23 | NSE | +6.68% |
| 2013 |
₹25872.25 Cr
$2.87B USD
|
₹1499.15 | NSE | +38.29% |
| 2012 |
₹18708.13 Cr
$2.08B USD
|
₹1084.03 | NSE | +11.46% |
| 2011 |
₹16784.74 Cr
$1.86B USD
|
₹972.58 | NSE | -16.78% |
| 2010 |
₹20170.23 Cr
$2.24B USD
|
₹1168.75 | NSE | +45.01% |
| 2009 |
₹13909.56 Cr
$1.55B USD
|
₹805.98 | NSE | +40.09% |
| 2008 |
₹9929.02 Cr
$1.10B USD
|
₹575.33 | NSE | +12.02% |
| 2007 |
₹8863.68 Cr
$984.85M USD
|
₹513.60 | NSE | -11.67% |
| 2006 |
₹10035.15 Cr
$1.12B USD
|
₹581.48 | NSE | +3.67% |
| 2005 |
₹9679.64 Cr
$1.08B USD
|
₹560.88 | NSE | +45.67% |
| 2004 |
₹6644.83 Cr
$738.31M USD
|
₹385.03 | NSE | +34.30% |
| 2003 |
₹4947.85 Cr
$549.76M USD
|
₹286.70 | NSE | - |